June 17, 2015 | The Israeli biopharmaceutical company Chiasma has filed with the US Securities & Exchange Commission to raise $86 million on NASDAQ. The filing comes just three months after raising $70 million in a private placement. The offering will be led by Barclay’s Capital and Cowen & Co. Chiasma was founded in 2001 and is headquartered in Jerusalem.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

UN Honors Israeli Food Exec For Sustainability Work
September 26, 2023

Startup Unveils Tech To Speed Up Growth Of Cultivated Meat
September 26, 2023

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Facebook comments